COMENTARIO A TIEMPO<\/p>\n
CUBA Y AM\u00c9RICA LATINA TIENEN SU PROPIA VACUNA ANTICOVID-19<\/p>\n
Por Teodoro Renter\u00eda Arr\u00f3yave<\/p>\n
Sin discusi\u00f3n, estamos ante un hecho cient\u00edfico hist\u00f3rico: Cuba ha desarrollado la primera vacuna anti Covid-19 la \u201cAbdala\u201d con una eficiencia del 92.8 por ciento, equiparable a las mejores que se han logrado en el llamado primer mundo.<\/p>\n
Primeramente, es de reconocerse el talento de los cient\u00edficos cubanos en muchos \u00f3rdenes, ahora nos toca destacar todo lo que han logrado en el terreno de la medicina y de los medicamentos.<\/p>\n
Nadie puede negar su avance en los campos de la cancerolog\u00eda, de la cardiolog\u00eda, de la geriatr\u00eda, de la pediatr\u00eda y en fin en el amplio espectro de la salud. Por eso Cuba ocupa el primer lugar en el mundo en baja mortalidad infantil.<\/p>\n
Ahora el propio presidente de Cuba, Miguel Diaz-Canel, mediante su felicitaci\u00f3n a los cient\u00edficos a cargo del desarrollo de vacunas nacionales, en dar a conocer al mundo el \u00edndice de 92.28 por ciento de eficacia del candidato anti Covid-19 Abdala.<\/p>\n
Tal haza\u00f1a cient\u00edfica no es s\u00f3lo para la Isla, es como lo decimos en el t\u00edtulo de esta entrega, es la primera vacuna desarrollada y confirmada de su gran eficacia en Cuba y en todo Am\u00e9rica Latina. Es para beneficio sobre todo de los pa\u00edses que luchan d\u00eda a d\u00eda contra las hegemon\u00edas mundiales<\/p>\n
\u201cEs una gran vacuna y el Centro de Ingenier\u00eda Gen\u00e9tica y Biotecnolog\u00eda (CIGB), es un centro grande con resultados grandes\u201d, precis\u00f3 el mandatario y agreg\u00f3: \u201cEn nombre de Cuba, felicitaciones\u201d.<\/p>\n
Por su parte, la directora del CIGB, Marta Ayala, agradeci\u00f3 a los m\u00e1s de 48 mil voluntarios de la fase III del ensayo de Abdala en las orientales provincias de Santiago de Cuba, Guant\u00e1namo y Granma.<\/p>\n
‘Es un homenaje a Jos\u00e9 Mart\u00ed, a Fidel (Castro), a Ra\u00fal (Castro) y a D\u00edaz-Canel, dedicado a los fundadores y a los actuales investigadores’, se\u00f1al\u00f3 la experta.<\/p>\n
Algunos datos t\u00e9cnicos: El CIGB confirm\u00f3 la elevada eficacia en esa jornada de su candidato en un esquema de tres dosis, \u201cCuba tendr\u00e1 dos vacunas que cumplen los requisitos m\u00ednimos de eficacia cl\u00ednica declarados por la Organizaci\u00f3n Mundial de la Salud, OMS\u201d: la mencionada Abadala y Soberana 02, que ten\u00eda un 62 por ciento en su esquema de dos dosis.<\/p>\n
No somos nuevos en el tema, desde que se estaban desarrollando los cuatro candidatos vacunales en la isla, los comentamos en estas entregas. Las investigaciones indudablemente contin\u00faan; por ahora nos unimos al regocijo isle\u00f1o, continental y tambi\u00e9n mundial porque Cuba y Am\u00e9rica Latina tienen su propia vacuna anti Covid-19.<\/p>\n
COMMENT ON TIME<\/p>\n
CUBA AND LATIN AMERICA HAVE THEIR OWN COVID-19 VACCINE<\/p>\n
By Teodoro Renteria Arr\u00f3yave<\/p>\n
<\/p>\n
Without discussion, we are facing a historical scientific fact: Cuba has developed the first vaccine against Covid-19 the \u00abAbdala\u00bb with an efficiency of 92.8 percent, comparable to the best that have been achieved in the so-called first world.<\/p>\n
First of all, the talent of Cuban scientists in many areas must be recognized, now we have to highlight all that they have achieved in the field of medicine and medicines.<\/p>\n
No one can deny its advancement in the fields of cancerology, cardiology, geriatrics, pediatrics and finally in the broad spectrum of health.\u00a0 That is why Cuba ranks first in the world in low infant mortality.<\/p>\n
Now the president of Cuba himself, Miguel Diaz-Canel, congratulating him to the scientists in charge of the development of national vaccines, in making known to the world the 92.28 percent efficacy rate of the anti-Covid-19 candidate Abdala.<\/p>\n
Such a scientific feat is not only for the Island, it is as we say in the title of this installment, it is the first vaccine developed and confirmed to be highly effective in Cuba and throughout Latin America.\u00a0 It is for the benefit above all of the countries that fight day by day against world hegemonies<\/p>\n
\u00abIt is a great vaccine and the Center for Genetic Engineering and Biotechnology (CIGB) is a large center with great results,\u00bb said the president, adding: \u00abOn behalf of Cuba, congratulations.\u00bb<\/p>\n
<\/p>\n
For her part, the director of the CIGB, Marta Ayala, thanked the more than 48,000 volunteers from phase III of Abdala’s trial in the eastern provinces of Santiago de Cuba, Guant\u00e1namo and Granma.<\/p>\n
\u00abIt is a tribute to Jos\u00e9 Mart\u00ed, Fidel (Castro), Ra\u00fal (Castro) and D\u00edaz-Canel, dedicated to the founders and current researchers,\u00bb said the expert.<\/p>\n
Some technical data: The CIGB confirmed the high efficacy of its candidate on that day in a three-dose scheme, \u00abCuba will have two vaccines that meet the minimum requirements of clinical efficacy declared by the World Health Organization, WHO\u00bb: the aforementioned Abadala and Soberana 02, which was 62 percent on their two-dose schedule.<\/p>\n
We are not new to the subject, since the four vaccine candidates were being developed on the island, we comment on them in these installments.\u00a0 Investigations are undoubte<\/p>\n
dly continuing;\u00a0 For now we join the island, continental and also global rejoicing because Cuba and Latin America have their own vaccine against Covid-19.<\/p>\n","protected":false},"excerpt":{"rendered":"
COMENTARIO A TIEMPO CUBA Y AM\u00c9RICA LATINA TIENEN SU PROPIA VACUNA ANTICOVID-19 Por Teodoro Renter\u00eda Arr\u00f3yave Sin discusi\u00f3n, estamos ante…<\/p>\n","protected":false},"author":2,"featured_media":27037,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,22],"tags":[],"class_list":["post-27036","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-internacional","category-portada-principal"],"_links":{"self":[{"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=\/wp\/v2\/posts\/27036"}],"collection":[{"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=27036"}],"version-history":[{"count":1,"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=\/wp\/v2\/posts\/27036\/revisions"}],"predecessor-version":[{"id":27038,"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=\/wp\/v2\/posts\/27036\/revisions\/27038"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=\/wp\/v2\/media\/27037"}],"wp:attachment":[{"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=27036"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=27036"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sinfronterasagencias.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=27036"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}